| Literature DB >> 22849854 |
Jia-Dai Zhai1, Dongmei Li, Jing Long, Hao-Liang Zhang, Jian-Ping Lin, Chuan-Jiang Qiu, Quan Zhang, Yue Chen.
Abstract
The semisynthesis of arglabin, an anticancer drug in clinical application, is developed from abundant natural product parthenolide via three steps. Each step in this sequence is highly stereoselective, and the substrate-dependent stereoselectivity in the epoxidation step can be explained by computational calculations. The success of chemical semisynthesis of arglabin suggests that the biosynthesis of arglabin might proceed in a similar pathway.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22849854 DOI: 10.1021/jo300888s
Source DB: PubMed Journal: J Org Chem ISSN: 0022-3263 Impact factor: 4.354